| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |